%0 Journal Article
%A Dunkl, V.
%A Cleff, C.
%A Stoffels, G.
%A Judov, N.
%A Sarikaya-Seiwert, S.
%A Law, I.
%A Bogeskov, L.
%A Nysom, K.
%A Andersen, S. B.
%A Steiger, H.-J.
%A Fink, G. R.
%A Reifenberger, G.
%A Shah, N. J.
%A Coenen, H. H.
%A Langen, K.-J.
%A Galldiks, N.
%T The usefulness of dynamic O-(2-18F-Fluoroethyl)-L-Tyrosine PET in the clinical evaluation of brain tumors in childrenand adolescents.
%J Journal of nuclear medicine
%V 56
%N 1
%@ 0161-5505
%C Reston, Va.
%I SNM
%M FZJ-2015-00158
%P 88-92
%D 2015
%X Experience regarding O-(2-18F-fluoroethyl)-l-tyrosine (18F-FET) PET in children and adolescents with brain tumors is limited. Methods: Sixty-nine 18F-FET PET scans of 48 children and adolescents (median age, 13 y; range, 1–18 y) were analyzed retrospectively. Twenty-six scans to assess newly diagnosed cerebral lesions, 24 scans for diagnosing tumor progression or recurrence, 8 scans for monitoring of chemotherapy effects, and 11 scans for the detection of residual tumor after resection were obtained. Maximum and mean tumor-to-brain ratios (TBRs) were determined at 20–40 min after injection, and time–activity curves of 18F-FET uptake were assigned to 3 different patterns: constant increase; peak at greater than 20–40 min after injection, followed by a plateau; and early peak (≤20 min), followed by a constant descent. The diagnostic accuracy of 18F-FET PET was assessed by receiver-operating-characteristic curve analyses using histology or clinical course as a reference. Results: In patients with newly diagnosed cerebral lesions, the highest accuracy (77%) to detect neoplastic tissue (19/26 patients) was obtained when the maximum TBR was 1.7 or greater (area under the curve, 0.80 ± 0.09; sensitivity, 79%; specificity, 71%; positive predictive value, 88%; P = 0.02). For diagnosing tumor progression or recurrence, the highest accuracy (82%) was obtained when curve patterns 2 or 3 were present (area under the curve, 0.80 ± 0.11; sensitivity, 75%; specificity, 90%; positive predictive value, 90%; P = 0.02). During chemotherapy, a decrease of TBRs was associated with a stable clinical course, and in 2 patients PET detected residual tumor after presumably complete tumor resection. Conclusion: Our findings suggest that 18F-FET PET can add valuable information for clinical decision making in pediatric brain tumor patients. 
%F PUB:(DE-HGF)16
%9 Journal Article
%U <Go to ISI:>//WOS:000347233700034
%$ pmid:25525183
%R 10.2967/jnumed.114.148734
%U https://juser.fz-juelich.de/record/186057